scispace - formally typeset
K

Klaus W. Frommer

Researcher at University of Giessen

Publications -  55
Citations -  1295

Klaus W. Frommer is an academic researcher from University of Giessen. The author has contributed to research in topics: Adipokine & Bone remodeling. The author has an hindex of 15, co-authored 53 publications receiving 1057 citations.

Papers
More filters
Journal ArticleDOI

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

TL;DR: A database to prospectively gather key data of patients with SSc using a minimal essential dataset provides an abundance of information on the true clinical face of SSc that will be helpful in improving the classification of S Sc and its subsets and for developing more specific therapeutic recommendations.
Journal ArticleDOI

Adiponectin-mediated changes in effector cells involved in the pathophysiology of rheumatoid arthritis.

TL;DR: The findings of the present study indicate that adiponectin induces gene expression and protein synthesis in human RASFs, lymphocytes, endothelial cells, and chondrocytes, supporting the concept of adip onectin being involved in the pathophysiologic modulation of RA effector cells.
Journal ArticleDOI

Adipocytokines as driving forces in rheumatoid arthritis and related inflammatory diseases

TL;DR: The current knowledge about the influence of central adipokines in rheumatic diseases, highlighting several aspects of the role of adipokine in chronic inflammation, is summarized.
Journal ArticleDOI

Adipokines in bone disease.

TL;DR: Current knowledge relating to adipokines in rheumatic diseases is summarized, with a particular focus on the effects of adipokine on bone remodelling.
Journal ArticleDOI

Free fatty acids: potential proinflammatory mediators in rheumatic diseases

TL;DR: The data show that FFA are not only metabolic substrates but may also directly contribute to articular inflammation and degradation in inflammatory joint diseases and require extracellular and intracellular access to the TLR4 receptor complex.